TAVERAS ARTHUR (Chief Scientific Officer) sold 5.7% of their position (14.23K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $12.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2024ACC: 0001628280-24-010281
Officer· Chief Scientific Officer
Since Nov 2020
-14.23K
Net shares
Net seller
$12.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.23K
Price / share
$0.88
Trade value
$12.55K
% of position
5.7%
3/11/2024
248.54K→234.30K
Total
Net shares
−14.23K
Net value
-$12.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | S · Sale | −14.23K | $0.88 | $12.55K | 5.7% | 248.54K | 234.30K |
| Total | −14.23K | -$12.55K | ||||||
Derivative Transactions0
No derivative transactions reported